Online citations, reference lists, and bibliographies.
← Back to Search

Augmentation Of Oral Methoxsalen-photochemotherapy With An Oral Retinoic Acid Derivative.

P. Fritsch, H. Hoenigsmann, E. Jaschke, K. Wolff
Published 1978 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
To improve the efficacy and reduce potential long-term hazards of photochemotherapy, we treated 36 patients with severe plaque-type psoriasis with a combination of oral methoxsalen-photochemotherapy (PUVA) and another oral chemotherapeutic agent, a retinoic acid derivative. Two groups of patients thus treated were cleared with 9.7 ± 4 treatments within 17.3 ± 7.6 days, and 6.3 ± 3.5 treatments within 11.0 ± 6.7 days, respectively; by contrast, 59 control patients treated with standard PUVA required 14.3 ± 7.8 treatments and 27.8 ± 15.2 days for clearing. Total cumulative doses of UVA energy required for clearing were 93.2 (mean) Joules/cm 2 for PUVA, and 36.2 (mean) Joules/cm 2 and 22.6 (mean) Joules/cm 2 , respectively, for the 2 patient groups receiving the combined treatment. 12 patients with severe palmoplantar psoriasis were cleared with 7 ± 3 treatments within 12.8 ± 5.5 days, requiring 21.4 ± 17.3 Joules/cm 2 . The combined treatment also cleared 11 patients who had been PUVA-treatment failures. The combined treatment thus considerably decreases the total energy of UVA required for PUVA alone; it accelerates the response of psoriasis to PUVA; and it is effective in the small group of patients who have to be considered PUVA failures. It is therefore more effective than PUVA and since it reduces the energy requirements of PUVA therapy it may diminish potential long-term hazards of this treatment.
This paper references
10.1111/j.1365-2133.1973.tb03014.x
The therapeutic value of retinoic acid in chronic discoid, acute guttate, and erythrodermic psoriasis: clinical observations on twenty‐five patients
S. Günther (1973)
10.1055/S-0028-1106568
Photochemotherapie bei Psoriasis
K. Wolff (1975)
10.1111/1523-1747.EP12496022
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.
J. Melski (1977)
10.1056/NEJM197412052912301
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.
J. Parrish (1974)
10.1111/j.1365-2133.1977.tb05177.x
Phototesting and dosimetry for photochemotherapy
K. Wolfff (1977)
Oral vitamin A acid therapy.
G. Stüttgen (1975)
10.1055/S-0028-1110177
[Vitamin A acid in hyperkeratoses, epithelial tumors and acne].
A. Schumacher (1971)
10.1038/JID.1958.128
On the specificity of the response of mouse epidermis to vitamin A.
D. J. Lawrence (1958)
10.1111/1523-1747.EP12680362
Growth stimulation of cultured postembryonic epidermal cells by vitamin A acid.
E. Christophers (1974)
[Treatment of psoriasis with an orally effective aromatic retinoid].
F. Ott (1977)
10.1111/j.1365-2133.1976.tb15541.x
Systemic use of a new retinoid with and without local dithranol treatment in generalized psoriasis
C. Orfanos (1976)
10.1159/000251079
Treatment of psoriasis vulgaris with a new retinoic acid derivative Ro 10-9359; An uncontrolled clinical trial.
B. Dahl (1977)
[Treatment of acne vulgaris using vitamin A acid].
E. Wolff-Schreiner (1975)
10.1001/ARCHDERM.1976.01630310005001
Photochemotherapy for psoriasis with orally administered methoxsalen.
K. Wolff (1976)
Kinetics of epidermis and adnexa following vitamin A acid in the human.
G. Plewig (1975)
Acne therapy with tretinoin in combination with antibiotics.
A. Kligman (1975)



This paper is referenced by
10.1007/978-3-642-81412-9_35
Neuere Entwicklungen in der Dermatologie
O. Braun-Falco (1979)
10.1111/J.1365-2133.1985.TB02302.X
Retinoids and PUVA in psoriasis.
K. Wolff (1984)
10.1111/j.1365-2230.1981.tb02372.x
Photochemotherapy in the treatment of psoriasis and mycosis fungoides *
A. Warin (1981)
10.3109/09546639709160520
The epidermis as a target for antipsoriatic treatment; the Nijmegen view
P. V. Kerkhof (1997)
10.1111/j.1365-2133.1991.tb00601.x
Relative efficacy of 335 and 365 nm radiation in photochemotherapy of psoriasis
J. Brücke (1991)
10.1111/j.1365-4362.1988.tb02413.x
Psoriasis Treatment with RePUVA in the United Arab Emirates
E. Darouti (1988)
10.1016/j.ejca.2017.02.027
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
F. Trautinger (2017)
10.1016/S0190-9622(82)70005-2
Combined methotrexate-PUVA therapy in the treatment of psoriasis.
W. Morison (1982)
10.1016/S0300-9084(86)80108-0
Problmes poss par l'utilisation thrapeutique des photosensibilisateurs en dermatologie
J.-C. Béani (1986)
10.1111/j.1468-3083.1993.tb00058.x
Acitretin in combination with PUVA: a randomized double‐blind placebo‐controlled study in severe psoriasis
C. Sommerburg (1993)
10.1111/j.1365-2230.1987.tb01873.x
Efficacy of etretinate for the PUVA‐dependent Psoriatic
R. A. Logan (1987)
10.1007/978-3-642-68023-6_83
The Use of Oral Aromatic Retinoids in Psoriasis Therapy: an Overview of Past, Present, and Future Developments
E. Farber (1981)
10.1007/978-3-642-60425-6_9
Photo- und Photochemotherapie: Seltenere Indikationen
A. Rütter (1997)
10.1111/j.1440-0960.1980.tb00161.x
THE COMBINATION OF ORAL AND TOPICAL PSORALEN WITH UVA
E. Lobel (1980)
10.1016/S0190-9622(83)70033-2
Recent advances in the treatment of psoriasis.
E. Farber (1983)
10.1016/0190-9622(91)70253-X
Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study.
A. Tanew (1991)
10.1016/1011-1344(92)85080-E
The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
M. Pathak (1992)
10.1111/j.1365-4362.1982.tb02071.x
The Risk of Photochemotherapy
G. Stüttgen (1982)
10.1111/j.1365-2133.1984.tb04051.x
Chronic actinic dermatitis
R. Camp (1984)
10.2340/00015555-0905
Systemic combination treatment for psoriasis: a review.
P. Jensen (2010)
10.1007/978-3-642-68023-6_26
Aromatic Retinoid (Ro 10-9359), RePUVA and PUVA in the Treatment of Psoriasis
J. Lauharanta (1981)
10.1001/ARCHDERM.1984.01650450051017
Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis.
K. M. Diette (1984)
10.1007/978-1-4615-3766-3_13
Phototherapy and Photochemotherapy of Psoriasis
T. Fitzpatrick (1991)
10.1111/j.1365-2133.1980.tb05692.x
Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10‐9359)
A. Lassus (1980)
10.1007/978-3-540-36693-5_9
Phototherapy and Photochemotherapy: Less Common Indications for Use
T. Schwarz (2009)
10.1111/j.1365-2133.1979.tb06196.x
Histopathology of remodelling induced by PUVA in the superficial dermis
G. Piérard (1979)
10.1111/j.1440-0960.1981.tb00036.x
THE RELATIONSHIP OF SKIN CANCER TO PUVA THERAPY IN AUSTRALIA
E. Lobel (1981)
10.1016/S0140-6736(83)92606-5
SYNERGISTIC CARCINOGENIC POTENTIAL OF METHOTREXATE AND PUVA IN PSORIASIS
C. Fitzsimons (1983)
10.1016/S0140-6736(83)92607-7
ISOTRETINOIN-PUVA FOR PSORIASIS
H. Hoenigsmann (1983)
10.1016/0163-7258(87)90093-3
Psoralens and related compounds in the treatment of psoriasis.
M. T. McEvoy (1987)
10.1016/B978-0-12-658102-7.50016-6
Synthetic Retinoids in Dermatology
G. L. Peck (1984)
10.1111/j.1365-2133.1990.tb01481.x
Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis
P. Petzelbauer (1990)
See more
Semantic Scholar Logo Some data provided by SemanticScholar